Literature DB >> 19733001

Transient receptor potential A1 and cannabinoid receptor activity in human normal and hyperplastic prostate: relation to nerves and interstitial cells.

Christian Gratzke1, Philipp Weinhold, Oliver Reich, Michael Seitz, Boris Schlenker, Christian G Stief, Karl-Erik Andersson, Petter Hedlund.   

Abstract

BACKGROUND: Ion channel transient receptor potential A1 (TRPA1) and cannabinoid (CB) receptors are involved in mechanoafferent signaling from the bladder and the urethra.
OBJECTIVE: To characterize TRPA1-, CB1-, and CB2-receptor activities in the human prostate. DESIGN, SETTING, AND PARTICIPANTS: Prostate specimens were obtained from 12 patients undergoing radical prostatectomy. We studied expressions (n=6) of TRPA1, CB1, and CB2 receptors and effects of the TRPA1 agonists allyl isothiocyanate (AI), cinnamaldehyde (CA), sodium hydrogen sulfide (NaHS), and CP 55940 (a CB1/CB2 agonist) on prostatic preparations. MEASUREMENTS: Western blot, immunohistochemistry, and functional experiments were performed. RESULTS AND LIMITATIONS: Western blot detected expected bands for CB1, CB2, and TRPA1. TRPA1 immunoreactivity was located on nerves that were positive for CB1, CB2, calcitonin gene-related peptide (CGRP), nitric oxide synthase (NOS), or vesicular acetylcholine transporter (VAChT). CB1 and CB2 immunoreactivity was found on nerves that were positive for NOS, VAChT, or CGRP. Adrenergic nerves were not immunoreactive for TRPA1, CB1, or CB2. In nodular hyperplasia, nerves containing the above markers were scarce or absent. TRPA1 immunoreactivity was detected in cyclic guanosine monophosphate-positive basal cells of the glandular epithelium. Basal or subepithelial TRPA1-immunoreactive cells contained vimentin and c-kit immunoreactivity. CA and NaHS relaxed precontracted preparations by 55±7% and 35±3% (n=6 for each). CP 55940, NaHS, AI, capsaicin, and CA decreased nerve contractions up to 27%, 80%, 47%, and 87%, respectively (n=6 for each).
CONCLUSIONS: The distribution and function of TRPA1 and CB receptors in prostatic tissue suggest a role for these receptors in mechanoafferent signals, epithelial homeostasis, emission, or inflammation of the human prostate.
Copyright © 2009 European Association of Urology. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19733001     DOI: 10.1016/j.eururo.2009.08.019

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  15 in total

Review 1.  The TRPA1 channel in migraine mechanism and treatment.

Authors:  S Benemei; C Fusi; Gabriela Trevisan; Pierangelo Geppetti
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 2.  The transient receptor potential channel TRPA1: from gene to pathophysiology.

Authors:  Bernd Nilius; Giovanni Appendino; Grzegorz Owsianik
Journal:  Pflugers Arch       Date:  2012-09-22       Impact factor: 3.657

Review 3.  The endocannabinoid system in prostate cancer.

Authors:  Inés Díaz-Laviada
Journal:  Nat Rev Urol       Date:  2011-09-13       Impact factor: 14.432

4.  Comparative immunohistochemical characterization of interstitial cells in the urinary bladder of human, guinea pig and pig.

Authors:  Clara Steiner; Thomas Gevaert; Roman Ganzer; Dirk De Ridder; Jochen Neuhaus
Journal:  Histochem Cell Biol       Date:  2018-02-20       Impact factor: 4.304

Review 5.  Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH).

Authors:  S Ventura; V l Oliver; C W White; J H Xie; J M Haynes; B Exintaris
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

6.  Expression and distribution of the transient receptor potential cationic channel A1 (TRPA1) in the human clitoris-comparison to male penile erectile tissue.

Authors:  S Ückert; K Albrecht; A Bannowsky; M Sohn; M A Kuczyk; P Hedlund
Journal:  Int J Impot Res       Date:  2017-05-04       Impact factor: 2.896

7.  Expression and distribution of the transient receptor potential cationic channel ankyrin 1 (TRPA1) in the human vagina.

Authors:  S Ückert; J E Sonnenberg; K Albrecht; M A Kuczyk; P Hedlund
Journal:  Int J Impot Res       Date:  2014-07-24       Impact factor: 2.896

Review 8.  Emerging drugs to target lower urinary tract symptomatology (LUTS)/benign prostatic hyperplasia (BPH): focus on the prostate.

Authors:  Stefan Ückert; George T Kedia; Dimitrios Tsikas; Annika Simon; Andreas Bannowsky; Markus A Kuczyk
Journal:  World J Urol       Date:  2019-09-10       Impact factor: 4.226

9.  A tarantula-venom peptide antagonizes the TRPA1 nociceptor ion channel by binding to the S1-S4 gating domain.

Authors:  Junhong Gui; Boyi Liu; Guan Cao; Andrew M Lipchik; Minervo Perez; Zoltan Dekan; Mehdi Mobli; Norelle L Daly; Paul F Alewood; Laurie L Parker; Glenn F King; Yufeng Zhou; Sven-Eric Jordt; Michael N Nitabach
Journal:  Curr Biol       Date:  2014-02-13       Impact factor: 10.834

Review 10.  TRPA1 as a drug target--promise and challenges.

Authors:  Jun Chen; David H Hackos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.